Posts

Posted on

High-Touch Support and Leading Technology Capabilities Bring Four Advisors to Ameriprise

High-Touch Support and Leading Technology Capabilities Bring Four Advisors to Ameriprise

Former Morgan Stanley and UBS advisors with $295 million in combined assets were attracted to Ameriprise’s resources for client service

MINNEAPOLIS–(BUSINESS WIRE)–
Ameriprise Financial, Inc. (NYSE: AMP) recently added four advisors to its employee channel with $295 million in combined client assets. Ross Perkins joined from UBSand separately Thomas Rodman, Maureen Cioppi-Grill, and Paul Teufel of Rodman, Grill & Associates joined Ameriprise from Morgan Stanley. The advisors found that Ameriprise offered them high-touch support and industry-leading technology capabilities to deliver superior service to clients.

UBS Advisor moves to Ameriprise to take advantage of the firm’s support approach Perkins, who joined Ameriprise in Carmel, Indiana from UBS, knew it was a big decision to make a move but decided now was the time. “I wanted a place I felt I could spend the rest of my career at, and Ameriprise felt like that firm. I now have a support system in place that allows me to integrate new technology into my practice,” he said.

Perkins is supported by Ameriprise branch manager Jeff Hodges. “We are excited to have Ross join our office. We have a strong, dynamic team supporting him to make a smooth transition, he’s thrilled that the firm’s capabilities are making a meaningful difference in his practice,” said Hodges. Perkins has $135 in assets under management.

Advisors from Morgan Stanley find more capabilities and efficiency at Ameriprise

“We knew Ameriprise was the right firm for us because of their longstanding commitment to clients and reliable technology capabilities that are critical as we’re meeting with more clients virtually due to the pandemic,” said Rodman. “With Ameriprise’s technology, we’ve been able to be more efficient with our time while maintaining the strong client relationships that we’ve had for decades.”

“We are thrilled with the wealth management and financial planning tools here. Ameriprise’s platform is more sophisticated and has the capabilities to help us meet our clients’ needs,” added Cioppi-Grill.

Rodman, Grill & Associates is located in Conshohocken, Pennsylvania and manages $160 million in assets under management. They are is supported by Ameriprise branch manager Mike Hartnett.

More than 4,300 financial advisors have joined Ameriprise since 2008.1 To find out why experienced financial advisors are joining Ameriprise, visit ameriprise.com/why.

About Ameriprise Financial

At Ameriprise Financial, we have been helping people feel confident about their financial future for more than 125 years. With extensive advisory, asset management and insurance capabilities and a nationwide network of approximately 10,000 financial advisors, we have the strength and expertise to serve the full range of individual and institutional investors’ financial needs. For more information, or to find an Ameriprise financial advisor, visit ameriprise.com.

Ameriprise Financial Services, LLC is an Equal Opportunity Employer.

Ameriprise Financial Services, LLC. Member FINRA and SIPC.

© 2020 Ameriprise Financial, Inc. All rights reserved.

 

1 Company data as of Q2 2020.

Stephanie Siegle, Media Relations

612.671.2593

[email protected]

KEYWORDS: Minnesota United States North America

INDUSTRY KEYWORDS: Consulting Professional Services Insurance Finance

MEDIA:

Logo
Logo
Posted on

Associa Northern California’s Kelly Zibell Elected to Community Associations Institute’s Community Managers Council

Pleasanton, CA, Nov. 12, 2020 (GLOBE NEWSWIRE) — Associa Northern California president, Kelly Zibell, PCAM®, was recently elected to the Community Associations Institute (CAI) Community Managers Council.  

The Community Managers Council represents all CAI community association manager members. The board consists of 12 members: four management company CEOs, two large-scale managers, four managers, and two at-large members. The council provides input on policy matters to the CAI board of trustees and serves as a key resource to staff. Appointees are elected to serve for two-year terms and may serve a maximum of six years on the council.  

Ms. Zibell has more than 17 years of community management experience with expertise in rental and portfolio management, administration, project management, and executive leadership. A member of the Associa team for more than a decade and the current Associa Northern California president, she leads client growth, employee and board member education, and relationship building with industry partners. 

“As a leader with vast experience in community management, Kelly has always been committed to serving the management industry with innovation, initiative, and a dedication to building long term relationships,” stated Ann Williams, Associa regional vice president. “Her approach to community issues and quality leadership will make her an asset to the Community Managers Council. We are excited to watch her excel in this role.” 

With more than 200 branch offices across North America, Associa delivers unsurpassed management and lifestyle services to nearly five million residents worldwide. Our 10,000+ team members lead the industry with unrivaled education, expertise and trailblazing innovation. For more than 40 years, Associa has provided solutions designed to help communities achieve their vision. To learn more, visit www.associaonline.com.

Stay Connected: 

Like us on Facebook: https://www.facebook.com/associa

Subscribe to the Blog: https://hub.associaonline.com/

Follow us on Twitter: https://twitter.com/associa

Join us on LinkedIn: http://www.linkedin.com/company/associa

Ashley Cantwell
Associa 
214-272-4107
[email protected]

Posted on

INVESTIGATION ALERT: Halper Sadeh LLP Reminds Shareholders About Its Ongoing Merger Investigations; Investors are Encouraged to Contact the Firm – CEIX, ELY, IPHI, DNKN, EIGI

PR Newswire

NEW YORK, Nov. 12, 2020 /PRNewswire/ — New York—Halper Sadeh LLP, a global investor rights law firm, announces it is investigating:


CONSOL Energy Inc. (NYSE: CEIX)

 concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its merger with CONSOL Coal Resources LP. Under the merger agreement, CONSOL Energy will acquire outstanding CCR common units at a fixed exchange ratio of 0.73 shares of CONSOL Energy common stock for each publicly held CCR common unit. If you are a CONSOL Energy shareholder, click on this link to learn more about your rights and options: https://halpersadeh.com/actions/consol-energy-inc-ceix-stock-merger-coal-resources/.


Callaway Golf Company (NYSE: ELY)

 concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its merger with Topgolf Entertainment Group. Under the terms of the merger agreement, Callaway will issue approximately 90 million shares of common stock to Topgolf shareholders. If you are a Callaway shareholder, click on this link to learn more about your legal rights and options: https://halpersadeh.com/actions/callaway-golf-company-ely-stock-merger-topgolf/.


Inphi Corporation (NASDAQ: IPHI)
 concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to Marvell Technology Group Ltd. for $66.00 in cash and 2.323 shares of stock of the combined company for each Inphi share. If you are an Inphi shareholder, click on this link to learn more about your legal rights and options: https://halpersadeh.com/actions/inphi-corporation-iphi-stock-merger-marvell/.


Dunkin’ Brands Group, Inc. (NASDAQ: DNKN)

 concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to Inspire Brands, Inc. for $106.50 per share. If you are a Dunkin’ shareholder, click on this link to learn more about your legal rights and options: https://halpersadeh.com/actions/dunkin-brands-group-inc-dnkn-stock-merger-inspire/.


Endurance International Group Holdings, Inc. (NASDAQ: EIGI)
 concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to affiliates of Clearlake Capital Group L.P. for $9.50 per share in cash. If you are an Endurance International shareholder, click on this link to learn more about your rights and options: https://halpersadeh.com/actions/endurance-international-group-holdings-inc-eigi-stock-merger-clearlake/.

Halper Sadeh LLP may seek increased consideration, additional disclosures and information concerning the proposed transaction, or other relief and benefits on behalf of shareholders.

Shareholders are encouraged to contact the firm free of charge to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email [email protected] or [email protected].

Halper Sadeh LLP represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:
Halper Sadeh LLP
Daniel Sadeh, Esq.
Zachary Halper, Esq.
(212) 763-0060
[email protected] 
[email protected]  
https://www.halpersadeh.com

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/investigation-alert-halper-sadeh-llp-reminds-shareholders-about-its-ongoing-merger-investigations-investors-are-encouraged-to-contact-the-firm–ceix-ely-iphi-dnkn-eigi-301172264.html

SOURCE Halper Sadeh LLP

Posted on

IFIC Makes Submission to FSRA on Financial Professionals Title Protection

TORONTO, Nov. 12, 2020 (GLOBE NEWSWIRE) — The Investment Funds Institute of Canada (IFIC) today made its submission to the Financial Services Regulatory Authority of Ontario (FSRA) on its proposed Financial Professionals Title Protection rule.

IFIC commends FSRA for striving to strengthen consumer confidence and understanding by introducing minimum standards for the use of the financial planner (FP) and financial advisor (FA) titles, without creating unnecessary burden for title users.

“To achieve this objective, we recommend that title users who are members of the Mutual Fund Dealers Association of Canada and the Investment Industry Regulatory Organization of Canada be exempted from the proposed rule,” said Paul Bourque, President and CEO, IFIC. “Without this exemption, these title users would be subject to duplicative and confusing rules without any additional investor or regulatory benefit.”

Other recommendations include: providing clients with a description of the products and services offered to clients; undertaking a regulatory impact analysis to weigh anticipated costs and benefits; and consulting with industry stakeholders on titles that are equivalent to FP or FA to reduce the risk of confusion.

About IFIC

The Investment Funds Institute of Canada is the voice of Canada’s investment funds industry. IFIC brings together 150 organizations, including fund managers, distributors and industry service organizations, to foster a strong, stable investment sector where investors can realize their financial goals. By connecting Canada’s savers to Canada’s economy, our industry contributes significantly to Canadian economic growth and job creation.

For more information:

Pira Kumarasamy
Senior Manager, Communications and Public Affairs
[email protected]
416-309-2317

Posted on

TI CEO Rich Templeton to speak at Credit Suisse investor conference

December 2, 2020, 10:50 a.m. Eastern time

PR Newswire

DALLAS, Nov. 12, 2020 /PRNewswire/ — Texas Instruments Incorporated (TI) (Nasdaq: TXN) Chairman, President and Chief Executive Officer Rich Templeton will speak at the virtual Credit Suisse 24th Annual Technology Conference on Tuesday, December 2, at 10:50 a.m. Eastern time. Templeton will field questions from analysts and investors, as well as discuss TI’s business outlook and its strategy to address key markets for its analog and embedded processing technologies and how these capabilities position the company for growth.

The audio webcast for the conference can be accessed live through the Investor Relations section (www.ti.com/ir) of TI’s website. An archived replay will be available on the website after his remarks.  

About Texas Instruments

Texas Instruments Incorporated (Nasdaq: TXN) is a global semiconductor company that designs, manufactures, tests and sells analog and embedded processing chips for markets such as industrial, automotive, personal electronics, communications equipment and enterprise systems. Our passion to create a better world by making electronics more affordable through semiconductors is alive today, as each generation of innovation builds upon the last to make our technology smaller, more efficient, more reliable and more affordable – making it possible for semiconductors to go into electronics everywhere. We think of this as Engineering Progress. It’s what we do and have been doing for decades. Learn more at TI.com.

TXN-G

 

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/ti-ceo-rich-templeton-to-speak-at-credit-suisse-investor-conference-301172245.html

SOURCE Texas Instruments Incorporated

Posted on

Liberty All-Star® Growth Fund, Inc. October 2020 Monthly Update

PR Newswire

BOSTON, Nov. 12, 2020 /PRNewswire/ — Below is the October 2020 Monthly Update for the Liberty All-Star Growth Fund, Inc. (NYSE: ASG)                       

Liberty All-Star Growth Fund, Inc.         
Ticker: ASG
Monthly Update, October, 2020       

Investment Approach:
Fund Style: All-Cap Growth             

Fund Strategy: Combines three growth style investment managers, each with a distinct capitalization focus (small-, mid- and large-cap) selected and continuously monitored by the Fund’s Investment Advisor.


Investment Managers:                     

          Weatherbie Capital, LLC
          Small-Cap Growth 
          Congress Asset Management Company, LLP
          Mid-Cap Growth 
          Sustainable Growth Advisers, LP 
          Large-Cap Growth

                               


Top 20 Holdings at Month-End         

  (31.3% of equity portfolio)       

1

FirstService Corp.                                     

2.1%

2

Paylocity Holding Corp.                               

2.1%

3

Nevro Corp.                                                  

2.1%

4

Chegg, Inc.                                                

2.0%

5

Microsoft Corp.                                             

1.7%

6

Visa, Inc.                                                     

1.6%

7

Alphabet, Inc.                                                 

1.6%

8

Facebook, Inc.                                              

1.6%

9

Amazon.com, Inc.                                     

1.6%

10

Insulet Corp.                                                 

1.5%

11

Generac Holdings, Inc                                  

1.4%

12

Progyny, Inc.                                                 

1.4%

13

Casella Waste Systems, Inc.                        

1.4%

14

ACADIA Pharmaceuticals, Inc.                   

1.4%

15

Workday, Inc.                                                

1.4%

16

Ollie’s Bargain Outlet Holdings, Inc.           

1.3%

17

Abbott Laboratories                                     

1.3%

18

Monolithic Power Systems, Inc.                   

1.3%

19

FleetCor Technologies, Inc.                        

1.3%

20

UnitedHealth Group, Inc.                              

1.2%

Holdings are subject to change.

 


Monthly Performance         

Performance                                       

    NAV               

   Market Price              

     Premium

Beginning of month value                  

$6.96

$7.11

2.2%

End of month value                          

$6.95

$7.20

3.6%

Performance for month                      

-0.14%

-1.27%

Performance year-to-date                  

19.92%

18.31%

 


Net Assets at Month-End ($millions)

Total                            

$291.0

Equities                       

$285.1

Percent Invested           

98.0%

 


Sector Breakdown (% of equity portfolio)*            

Information Technology                    

30.3%

Health Care                                        

26.1%

Consumer Discretionary                  

12.5%

Industrials                                           

12.4%

Financials                                           

4.8%

Communication Services                   

4.6%

Real Estate                                        

3.9%

Materials                                            

3.0%

Consumer Staples                              

2.1%

Energy                                               

0.3%

Total Market Value                              

100.0%

*Based on Standard & Poor’s and MSCI Barra Global Industry Classification Standard (GICS).

 


New Holdings

Eargo, Inc.     

Entegris, Inc.

 


Holdings Liquidated

Varian Medical Systems, Inc.

 

The net asset value (NAV) of a closed-end fund is the market value of the underlying investments (i.e., stocks and bonds) in the Fund’s portfolio, minus liabilities, divided by the total number of Fund shares outstanding. However, the Fund also has a market price; the value at which it trades on an exchange. If the market price is above the NAV the Fund is trading at a premium. If the market price is below the NAV the Fund is trading at a discount.

Performance returns for the Fund are total returns, which includes dividends, and are net of management fees and other Fund expenses. Returns are calculated assuming that a shareholder reinvested all distributions and all primary rights in the Fund’s rights offering were exercised. Past performance cannot predict future investment results.

Performance will fluctuate with changes in market conditions. Current performance may be lower or higher than the performance data shown. Performance information shown does not reflect the deduction of taxes that shareholders would pay on Fund distributions or the sale of Fund shares. Shareholders must be willing to tolerate significant fluctuations in the value of their investment. An investment in the Fund involves risk, including loss of principal.

Sources of distributions to shareholders may include ordinary dividends, long-term capital gains and return of capital.   The final determination of the source of all distributions in 2020 for tax reporting purposes will be made after year end.  The actual amounts and sources of the amounts for tax reporting purposes will depend upon the Fund’s investment experience during its fiscal year and may be subject to changes based on tax regulations. Based on current estimates no portion of the distributions consists of a return of capital. These estimates may not match the final tax characterization (for the full year’s distributions) contained in shareholder 1099-DIV forms after the end of the year.                    

All data is as of October 31, 2020 unless otherwise noted. 

Liberty All-Star® Growth Fund, Inc.
1-800-241-1850
www.all-starfunds.com
[email protected]                           

                                   

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/liberty-all-star-growth-fund-inc-october-2020-monthly-update-301172260.html

SOURCE Liberty All-Star Growth Fund, Inc.

Posted on

Liberty All-Star Equity Fund October 2020 Monthly Update

PR Newswire

BOSTON, Nov. 12, 2020 /PRNewswire/ — Below is the October 2020 Monthly Update for the Liberty All-Star Equity Fund. (NYSE: USA)

Liberty All-Star Equity Fund
Ticker: USA
Monthly Update, October, 2020

Investment Approach:
Fund Style: Large-Cap Core
Fund Strategy: Combines three value-style and two growth-style investment managers. Those selected demonstrate a consistent investment philosophy, decision making process, continuity of key people and above-average long-term results compared to managers with similar styles.


Investment Managers:

Value Managers:

Aristotle Capital Management, LLC 

Fiduciary Management, Inc.              

Pzena Investment Management, LLC                       

Growth Managers:

Sustainable Growth Advisers, LP     

TCW Investment Management Company

 


Top 20 Holdings at Month-End

(32.8% of equity portfolio)

1

Amazon.com, Inc.

2.6%

2

PayPal Holdings, Inc.

2.2%

3

Adobe, Inc.

2.2%

4

Alphabet, Inc.

2.2%

5

Facebook, Inc.

2.1%

6

Visa, Inc.

2.0%

7

Danaher Corp.

1.9%

8

Microsoft Corp.

1.9%

9

salesforce.com, Inc.

1.8%

10

UnitedHealth Group, Inc.

1.6%

11

Sony Corp.

1.5%

12

JPMorgan Chase & Co.

1.4%

13

ServiceNow, Inc.

1.4%

14

Berkshire Hathaway, Inc.

1.3%

15

Chubb, Ltd.

1.3%

16

IHS Markit, Ltd.

1.2%

17

Equinix, Inc.

1.2%

18

Capital One Financial Corp.

1.0%

19

Masco Corp.

1.0%

20

Dollar General Corp.

1.0%

Holdings are subject to change.

 


Monthly Performance:

Performance

NAV

Market Price

Discount

Beginning of month value

$6.46

$6.01

-7.0%

End of month value

$6.43

$5.80

-9.8%

Performance for month

-0.46%

-3.49%

Performance year-to-date

0.58%

-7.54%

           


Net Assets at Month-End ($millions)

Total

$1,382.7

Equities

$1,345.4

Percent Invested

97.3%

 


Sector Breakdown (% of equity portfolio)*

Information Technology

22.1%

Financials

15.7%

Health Care

14.8%

Consumer Discretionary

14.2%

Industrials

12.1%

Communication Services

6.3%

Materials

4.6%

Consumer Staples

3.7%

Energy

3.1%

Real Estate

2.6%

Utilities

0.8%

Total Market Value

100.0%

*Based on Standard & Poor’s and MSCI Barra Global Industry Classification Standard (GICS).

New Holdings
Edison International
Micron Technology, Inc.

Holdings Liquidated

Stanley Black & Decker, Inc.

The net asset value (NAV) of a closed-end fund is the market value of the underlying investments (i.e., stocks and bonds) in the Fund’s portfolio, minus liabilities, divided by the total number of Fund shares outstanding. However, the Fund also has a  market price; the value at which it trades on an exchange. If the market price is above  the NAV the Fund is trading at a premium. If the market price is below the NAV the Fund is trading at a discount.

Performance returns for the Fund are total returns, which includes dividends, and are net of management fees and other Fund expenses. Returns are calculated assuming that a shareholder reinvested all distributions. Past performance cannot predict future investment results.

Performance will fluctuate with changes in market conditions. Current performance may be lower or higher than the performance data shown. Performance information shown does not reflect the deduction of taxes that shareholders would pay on Fund distributions or the sale of Fund shares. Shareholders must be willing to tolerate significant fluctuations in the value of their investment. An investment in the Fund involves risk, including loss of principal.

Sources of distributions to shareholders may include ordinary dividends, long-term capital gains and return of capital.  The final determination of the source of all distributions in 2020 for tax reporting purposes will be made after year end.  The actual amounts and sources of the amounts for tax reporting purposes will depend upon the Fund’s investment experience during its fiscal year and may be subject to changes based on tax regulations. Based on current estimates a portion of the distributions consists of a return of capital. These estimates may not match the final tax characterization (for the full year’s distributions) contained in shareholder 1099-DIV forms after the end of the year.                    

All data is as of October 31, 2020 unless otherwise noted.              

Liberty All-Star® Equity Fund
1-800-241-1850
www.all-starfunds.com
[email protected]

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/liberty-all-star-equity-fund-october-2020-monthly-update-301172256.html

SOURCE Liberty All-Star Funds

Posted on

AM Best Affirms Credit Ratings of Castle Harbour Insurance Limited and Harrington Sound Insurance Limited

AM Best Affirms Credit Ratings of Castle Harbour Insurance Limited and Harrington Sound Insurance Limited

OLDWICK, N.J.–(BUSINESS WIRE)–AM Best has affirmed the Financial Strength Rating (FSR) of A (Excellent) and the Long-Term Issuer Credit Ratings (Long-Term ICR) of “a+” of Castle Harbour Insurance Limited (Castle Harbour) and Harrington Sound Insurance Limited (Harrington). These companies are captive insurance companies for Schlumberger Limited (Schlumberger) [NYSE:SLB]. The outlook of these Credit Ratings (ratings) is stable. Both captives are domiciled in Bermuda.

The ratings of Castle Harbour and Harrington reflect their balance sheet strength, which AM Best categorizes as strongest, as well as their strong operating performance, neutral business profile and appropriate enterprise risk management (ERM).

The companies are captive insurance companies for Schlumberger, a leading provider of technology, integrated project management and information solutions to customers working in the oil and gas industry worldwide. The ratings reflect that Castle Harbour and Harrington maintain the strongest level of risk-adjusted capitalization, as measured by Best’s Capital Adequacy Ratio (BCAR). In addition to excellent operating performance over several years, the ratings take into consideration the important role the captives play in providing their parent customized insurance coverages. The captives carry relatively large limits in the general liability and property lines of business; however, each writes a broad scope of business and has significant geographic diversification. ERM practices are appropriate given the conservative risk culture across the Schlumberger enterprise, defined controls and optimization of the captives’ capital and surplus. Further, AM Best recognizes the financial flexibility afforded the captives by their parent company as well as their strategic importance across Schlumberger.

AM Best remains the leading rating agency of alternative risk transfer entities, with more than 200 such vehicles rated in the United States and throughout the world. For current Best’s Credit Ratings and independent data on the captive and alternative risk transfer insurance market, please visit www.ambest.com/captive.

This press release relates to Credit Ratings that have been published on AM Best’s website. For all rating information relating to the release and pertinent disclosures, including details of the office responsible for issuing each of the individual ratings referenced in this release, please see AM Best’s Recent Rating Activity web page. For additional information regarding the use and limitations of Credit Rating opinions, please view Guide to Best’s Credit Ratings. For information on the proper media use of Best’s Credit Ratings and AM Best press releases, please view Guide for Media – Proper Use of Best’s Credit Ratings and AM Best Rating Action Press Releases.

AM Best is a global credit rating agency, news publisher and data analytics provider specializing in the insurance industry. Headquartered in the United States, the company does business in over 100 countries with regional offices in New York, London, Amsterdam, Dubai, Hong Kong, Singapore and Mexico City. For more information, visit www.ambest.com.

Copyright © 2020 by A.M. Best Rating Services, Inc. and/or its affiliates. ALL RIGHTS RESERVED.

Adrienne Stark

Senior Financial Analyst

+1 908 439 2200, ext. 5526

[email protected]

Christopher Sharkey

Manager, Public Relations

+1 908 439 2200, ext. 5159

[email protected]

Dan Teclaw

Senior Financial Analyst

+1 908 439 2200, ext. 5394

[email protected]

Jim Peavy

Director, Communications

+1 908 439 2200, ext. 5644

[email protected]

KEYWORDS: Europe United States North America New Jersey

INDUSTRY KEYWORDS: Insurance Professional Services

MEDIA:

Logo
Logo
Posted on

INTERCEPT PHARMACEUTICALS, INC. CLASS ACTION ALERT: Wolf Haldenstein Adler Freeman & Herz LLP Announces That a Securities Class Action Lawsuit has Been Filed on Behalf of Shareholders of Intercept Pharmaceuticals, Inc.

Impending Lead Plaintiff Deadline is January 4, 2021

NEW YORK, Nov. 12, 2020 (GLOBE NEWSWIRE) — Wolf Haldenstein Adler Freeman & Herz LLP (“Wolf Haldenstein”) announces that a federal securities class action lawsuit has been filed in the United States District Court for the Southern District of New York on behalf of investors who purchased or otherwise acquired Intercept Pharmaceuticals, Inc. (“Intercept” or the “Company”) (NASDAQ: ICPT) securities between September 28, 2019 and October 7, 2020 inclusive (the “Class Period”).

All
i
nvestors
who
purchased
shares
of
Intercept Pharmaceuticals, Inc.
a
nd
incurred losses
a
re
u
rged
to contact the firm
i
mmediately at

[email protected]

or (800) 575-0735 or (212) 545-4774.
You may obtain additional information conc
erning the action or

join the case

on our
website
,

www.whafh.com.

If you have incurred losses in the shares of Intercept Pharmaceuticals, Inc.,you may,nolater than January 4, 2021,   request that the Court appoint you lead plaintiff of the proposed class.  


CLICK HERE TO JOIN THIS CASE

The filed complaint alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company’s business, operations, and prospects. Specifically, Defendants failed to disclose to investors that:

  • Defendants downplayed the true scope and severity of safety concerns associated with Ocaliva’s use in treating PBC;
  • the foregoing increased the likelihood of an FDA investigation into Ocaliva’s development, thereby jeopardizing Ocaliva’s continued marketability and the sustainability of its sales;
  • any purported benefits associated with OCA’s efficacy in treating NASH were outweighed by the risks of its use;
  • as a result, the FDA was unlikely to approve the Company’s NDA for OCA in treating patients with liver fibrosis due to NASH; and
  • as a result of all the foregoing, the Company’s public statements were materially false and misleading at all relevant times.

On May 22, 2020, Intercept stated that the U.S. Food and Drug Administration (“FDA”) “has notified Intercept that its tentatively scheduled June 9, 2020 advisory committee meeting (AdCom) relating to the company’s [NDA] for [OCA] for the treatment of liver fibrosis due to [NASH] has been postponed” to “accommodate the review of additional data requested by the FDA that the company intends to submit within the next week.”

On this news, Intercept’s stock price fell $11.18 per share, or 12%, to close at $80.51 per share on May 22, 2020.

On June 29, 2020, Intercept disclosed receipt of a Complete Response Letter (“CRL”) from the FDA rejecting its NDA for Ocaliva for the treatment of liver fibrosis due to NASH. According to the CRL, “[t]he FDA recommends that Intercept submit additional post-interim analysis efficacy and safety data from the ongoing REGENERATE study in support of potential accelerated approval and that the long-term outcomes phase of the study should continue.”

On this news, the Company’s stock price fell $30.79 per share, or nearly 40%, to close at $46.70 per share on June 29, 2020.

On October 8, 2020, news outlets reported that the Company was “facing an investigation from the [FDA] over the potential risk of liver injury in patients taking Ocaliva, [Intercept’s] treatment for primary biliary cholangitis, a rare, chronic liver disease.”

On this news, the Company’s stock price fell an additional $3.30 per share, or 8%, to close at $37.69 per share on October 8, 2020.

Wolf Haldenstein has extensive experience in the prosecution of securities class actions and derivative litigation in state and federal trial and appellate courts across the country. The firm has attorneys in various practice areas; and offices in New York, Chicago and San Diego. The reputation and expertise of this firm in shareholder and other class litigation has been repeatedly recognized by the courts, which have appointed it to major positions in complex securities multi-district and consolidated litigation.

If you wish to discuss this action or have any questions regarding your rights and interests in this case, please immediately contact Wolf Haldenstein by telephone at (800) 575-0735, via e-mail at [email protected], or visit our website at www.whafh.com.

Contact:

Wolf Haldenstein Adler Freeman & Herz LLP
Kevin Cooper, Esq.
Gregory Stone, Director of Case and Financial Analysis
Email: [email protected], [email protected] or [email protected]
Tel: (800) 575-0735 or (212) 545-4774

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Posted on

BioSig to Host Business Update Conference Call on November 18, 2020

Westport, CT, Nov. 12, 2020 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing a proprietary biomedical signal processing platform designed to improve signal fidelity and uncover the full range of ECG and intra-cardiac signals, today announced that it would host a call on November 18, 2020, at 4:15 PM ET. Kenneth L. Londoner, Chairman, and CEO of BioSig Technologies, Inc. will review highlights from the Company’s third quarter of 2020 and discuss corporate initiatives, including ongoing PURE EP™ System installations and commercialization outlook.

Conference Call Details

Date: Wednesday, November 18, 2020
Time: 4:15 PM Eastern Time (ET)
Dial in Number: +1 877-407-8293 / 201-689-8349

A replay will be available for two weeks starting on November 18, 2020, at approximately 7:15 PM ET. To access the replay, please dial +1 877-660-6853 / 201-612-7415. The conference ID# is 13713315.

BioSig’s PURE EP™ System is currently installed in six medical centers across the country. More than 350 patient cases have been completed with the PURE EP™ System to date. BioSig is presently enrolling patients in the clinical trial titled “Novel Cardiac Signal Processing System for Electrophysiology Procedures (PURE EP 2.0 Study)” at Texas Cardiac Arrhythmia Research Foundation (TCARF) in Austin, Texas and Mayo Clinic Florida Campus in Jacksonville, Florida.

About BioSig Technologies

BioSig Technologies is a medical technology company commercializing a proprietary biomedical signal processing platform designed to improve signal fidelity and uncover the full range of ECG and intra-cardiac signals (www.biosig.com).

The Company’s first product, PURE EP ™ System is a computerized system intended for acquiring, digitizing, amplifying, filtering, measuring and calculating, displaying, recording and storing of electrocardiographic and intracardiac signals for patients undergoing electrophysiology (EP) procedures in an EP laboratory.

Forward-looking Statements

This press release contains “forward-looking statements.” Such statements may be preceded by the words “intends,” “may,” “will,” “plans,” “expects,” “anticipates,” “projects,” “predicts,” “estimates,” “aims,” “believes,” “hopes,” “potential” or similar words. Forward- looking statements are not guarantees of future performance, are based on certain assumptions and are subject to various known and unknown risks and uncertainties, many of which are beyond the Company’s control, and cannot be predicted or quantified and consequently, actual results may differ materially from those expressed or implied by such forward-looking statements. Such risks and uncertainties include, without limitation, risks and uncertainties associated with (i) the geographic, social and economic impact of COVID-19 on our ability to conduct our business and raise capital in the future when needed, (ii) our inability to manufacture our products and product candidates on a commercial scale on our own, or in collaboration with third parties; (iii) difficulties in obtaining financing on commercially reasonable terms; (iv) changes in the size and nature of our competition; (v) loss of one or more key executives or scientists; and (vi) difficulties in securing regulatory approval to market our products and product candidates. More detailed information about the Company and the risk factors that may affect the realization of forward-looking statements is set forth in the Company’s filings with the Securities and Exchange Commission (SEC), including the Company’s Annual Report on Form 10-K and its Quarterly Reports on Form 10-Q. Investors and security holders are urged to read these documents free of charge on the SEC’s website at http://www.sec.gov. The Company assumes no obligation to publicly update or revise its forward-looking statements as a result of new information, future events or otherwise. 

Andrew Ballou
BioSig Technologies, Inc. 
Vice President, Investor Relations 
54 Wilton Road, 2nd floor
Westport, CT 06880
[email protected]
203-409-5444, x133